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Summary
The mannopeptimycins (MPPs) are potent glycopep-
tide antibiotics that contain both D and L forms of the
unique, arginine-derived amino acid b-hydroxyendur-
acididine (bhEnd). The product of the mppO gene in
the MPP biosynthetic cluster resembles several non-
heme iron, a-ketoglutarate-dependent oxygenases,
such as VioC and clavaminate synthase. The role of
MppO in bhEnd biosynthesis was confirmed through
inactivation of mppO, which yielded a strain that pro-
duced dideoxy-MPPs, indicating that mppO is essen-
tial for generating the b-hydroxy functionality for both
bhEnd residues. Characterization in vitro of recombi-
nant His6-MppO expressed in E. coli revealed that
MppO selectively hydroxylates the b carbon of free
L-enduracididine.
Introduction
The mannopeptimycins (MPPs), produced by Strepto-
myces hygroscopicusNRRL 30439, are a group of cyclic
glycopeptide antibiotics with potent activity against
methicillin-resistant staphylococci and vancomycin-
resistant enterococci (Figure 1) [1]. The MPPs are distin-
guished by the presence of two stereoisomers of the
nonproteinogenic amino acid b-hydroxyenduracididine
(e.g., MPP-g, 1) [2]. The route of b-hydroxyenduracidi-
dine (bhEnd) formation is not known, but the presence
of a guanidine moiety suggests that bhEnd is derived
from arginine. Arginine is also the precursor to capreo-
mycidine, an amino acid possessing a six-membered
cyclic guanidine side chain that is common to the tuber-
actinomycin antibiotics, including viomycin [3]. VioC is
a non-heme iron, a-ketoglutarate-dependent oxygen-
ase that operates in the viomycin pathway and converts
free L-Arg to 3S-OH-L-Arg [4, 5]. VioD, the product of the
gene immediately downstream of vioC, then catalyzes
the pyridoxal phosphate-dependent conversion of 3S-
OH-L-Arg to 2S,3R-capreomycidine [5, 6].
*Correspondence: haltlib@wyeth.com (B.H.); mark.zabriskie@orst.
edu (T.M.Z.)The MPP biosynthetic gene cluster (N.A.M. et al., sub-
mitted) contains a gene (mppO) with a deduced amino
acid sequence that showed end-to-end similarity to VioC
(58% similarity, 42% identity) and clavaminate synthase
(46% similarity, 31% identity) [7–9]. Clavaminate syn-
thase (CS) is another Fe(II)/a-ketoglutarate-dependent
oxygenase that catalyzes nonsequentialb-hydroxylation,
oxidative cyclization, and dehydrogenation reactions in
the conversion of deoxyguanidinoproclavaminic acid to
the b-lactamase inhibitor clavulanic acid [9]. Based on
the similarity to CS and VioC, we predicted that MppO
would catalyze one or more reactions in the conversion
of L-Arg to bhEnd. We report here the results ofmppO in-
activation experiments in the producing organism and
the in vitro enzymatic characterization of His6-MppO.
Results and Discussion
Sequence Analysis
The predicted product of mppO consists of 341 amino
acids and shows significant similarity to CS1 and CS2
[9] and several CS-like proteins, including VioC [7, 8].
In addition to the overall similarity, MppO and its homo-
logs possess a 2-His-1-carboxylate motif common to
non-heme iron oxygenases [10]. This motif is generally
characterized by the sequence His-Xaa-Asp/Glu53-59-
His and is responsible for binding Fe(II). A variant of
this model was proposed to describe the key active
site residues of CS2 [11]. In the His-3 variant of the 2-
His-1-carboxylate model, the second active site histi-
dine residue is separated from the first by 134 aa. In their
examination of a-ketoglutarate-dependent, non-heme
oxygenases, Khaleeli et al. [11] identified a subset of en-
zymes that exhibit the His-3 motif, and X-ray crystallog-
raphy confirmed involvement of the His-1 and His-3 mo-
tifs in binding Fe(II) [12–14]. MppO and its homologs
(Figure 2) also contain the characteristic His-1 (HXE)
and His-3 (DNXXXXH) motifs, and the spacing between
these motifs (131–153 aa) is consistent with that ob-
served for CS1 and CS2 (134 aa). Based on these obser-
vations, MppOand itshomologs likelybelong to the His-3
variant group of non-heme iron oxygenases.
Inactivation of mppO in S. hygroscopicus
NRRL 30439
Toassess the roleofmppO inMPPbiosynthesis, the gene
was inactivated in the producing organism by replacing
a 762 bp fragment of the gene with the kanamycin-
resistance gene aphII. Deletion of the 762 bp fragment
removed the entire His-1 motif predicted to be required
for Fe(II) binding. The disruption construct (pBWA29)
was introduced into S. hygroscopicus NRRL 30439 by
intergeneric conjugation (N.A.M. et al., submitted). Kana-
mycin-resistant colonies were selected and screened for
double crossover events by Southern blot analysis, and
one exconjugant (WPN105) was found in which mppO
had been replaced with aphII (data not shown).
The metabolite profiles of the wild-type and mppO2
mutant strains were analyzed by LC/MS. The wild-type
culture produced primarily MPP-g, -d, and -3, whereas
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Figure 1. Structure of Natural Mannopepti-
mycins Produced by S. hygroscopicus NRRL
30439
The L-bhEnd residue is blue, and the D-bhEnd
residue is red.the mutant produced a similar array of compounds ex-
hibiting the same UV profile as the MPPs, but having dif-
ferent retention times and masses that corresponded to
a loss of two oxygen atoms (HRFTMS-ESI calculated for
C59H88N12O24
2+ [M + 2H]2+ 674.30117; found 674.30054).
Presumably, this finding reflects the absence of two hy-
droxyl groups. Interestingly, MPP titers from the wild-
type and mutant strains were similar, despite evidence
from investigation of the MPP adenylation (A) domain
substrate specificity that revealed that bhEnd was
clearly the preferred substrate and enduracididine
(End) was activated at levels similar to negative controls
(N.A.M., submitted). A more detailed examination of the
bhEnd-incorporating A domain and investigation of pos-
sible contributions of the bhEnd-incorporating conden-
sation domains to substrate selectivity is needed.
To determine if the missing hydroxyl groups were from
the bhEnd residues or the mannose units, the purifiedproduct from the mppO mutant fermentation was com-
pared by LC/MS to authentic dideoxy-MPP-g and -d.
The authentic samples were isolated from an N-methyl-
N0-nitro-N-nitroso-guanidine (NTG)-mutagenized strain
of S. hygroscopicus NRRL 30439 that produces MPPs
in which the b carbons of both End residues are not
hydroxylated (J. Lotvin, personal communication). Coin-
jection resulted in an increase in the amount of dideoxy-
MPP-g (Figure 3), confirming that MppO is responsible
for introducing the b-hydroxy group of both the D- and
L-bhEnd residues.
Sequence Analysis of the NTG-Mutagenized
Dideoxy-MPP Producer
To verify if a lesion in mppO in the NTG mutant (NRRL
30450) was responsible for the phenotype, mppO was
amplified from the genomes of the wild-type (NRRL
30439) and mutant strains (NRRL 30450 and NRRLA B
AsnO 153 aa AFHE –105 aa- VTHRLLPGELAIVDNRVTVHGRTEFTPR 
SttL 152 aa AFHP –122 aa- REVVADQGDVLFIDNHRAVHGRLPFKAH 
VioC 142 aa AFSP –121 aa- YELVLDQGDVAFIDNRRAVHGRRAFQPR 
MppO 144 aa AFHP –127 aa- SGVVLSPGDIVFIDNYRVVHGRKPFRAR 
CS1 143 aa AYHI –108 aa- VGVKLVPGDVLIIDNFRTTHARTPFSPR 
CS2 152 aa
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Figure 2. Sequence Alignment of Key Motifs
Found MppO and Related Proteins
ClustalW alignment of (A) His-1, (B) His-3, and
(C) His-2 motifs of MppO and its homologs.
Results are shown for AsnO from Strepto-
myces coelicolor [17], SttL from Streptomy-
ces rochei F20 (direct deposit to the data
bank by F. Malpartida, accession number
CAB67713), VioC from Streptomyces vina-
ceus [7, 8], MppO from Streptomyces hygro-
scopicus NRRL 30439 [10], and CS1 and
CS2 from Streptomyces clavuligerus [9]. In-
variant residues are indicated with an aster-
isk. Positions with conservative substitutions
are indicated with a colon. Positions with
semiconservative substitutions are indicated
with a period. Residues proven to be essential
for CS2 activity are shaded. The residue pro-
posed by this study to affect activity of
MppO is in bold type.
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116530443). S. hygroscopicus NRRL 30443 is the parent
strain of NRRL 30450 and produces the normal suite of
MPPs.mppOwas amplified from each strain by PCR and
was cloned into pCR-BluntII. Eight clones from each
strain were sequenced. There was no difference in the
mppO sequences from the wild-type strain and NRRL
30443. However, a single point mutation (C/T) at nucle-
otide 450 was identified in mppO from the NRRL 30450
strain. This mutation results in a conservative change
wherein an invariant alanine at position 150 is mutated
to valine. This mutation does not directly affect residues
in the predicted active site (Figure 2), but it is proximal to
the essential residues of the His-1 motif (H146 and E148),
and the added bulk may hinder the ability to bind Fe(II).
Functional Expression and Characterization
of MppO
To complement the gene disruption results and address
MppO substrate and stereospecificity issues,mppOwas
amplified by PCR and cloned into pET28a for expression
in E. coli. This construct was expected to yield a protein
with an N-terminal His6 tag and a calculated molecular
weight of 38.6 kDa. After expression, the recombinant
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Figure 3. LC/MS Comparison of Putative Dideoxy-MPP-g Isolated
from Mutant WPN105 to Authentic Dideoxy-MPP-g and -dStandards
(A) Dideoxy-MPP-g and -d standards.
(B) Putative dideoxy-MPP-g isolated from mutant WPN105.
(C) Coinjection of (A) and (B).protein was purified by metal affinity chromatography,
and the efficiency of purification was verified by SDS-
PAGE (Figure 4A).
Purified His6-MppO assays included 1 mM a-ketoglu-
tarate, 25 mM FeSO4, 0.5 mM dithiothreitol (DTT), 0.1 mM
ascorbate, and either 2 mM D,L-End, 1 mM L-Arg, or 1
mM dideoxy-MPP-g. Reaction mixtures were incubated
at 30ºC for various times, the protein was precipitated,
and the supernatant was treated with dansyl chloride
(DNS-Cl) to permit HPLC analysis with UV detection (the
assay containing dideoxy-MPP-g did not require deriva-
tization) [4]. When D,L-End was used as a substrate, a
new peak appeared in the HPLC chromatogram that
was dependent on MppO, Fe(II), and a-ketoglutarate
(Figure 4B). The product was confirmed to be bhEnd by
coinjection analysis with authentic bhEnd obtained from
the acid hydrolysate of MPP. There were no detectable
products when L-Arg or dideoxy-MPP-g were used as
substrate.
Because the enduracididine used as substrate in the
MppO assays was obtained by hydrolysis of dideoxy-
MPP, both D and L forms were present. To examine the
stereospecificity of MppO, samples of D,L-End were pre-
incubated with either D-amino acid oxidase (D-AAO) or
L-amino acid oxidase (L-AAO) to destroy the D and L iso-
mers, respectively. Preincubation of D,L-End with L-AAO
resulted in a significant decrease in the amount of bhEnd
produced by MppO (Figure 4C). The small amount of
bhEnd still detected is presumably due to incomplete re-
moval of L-End. Preincubation with D-AAO had no effect
on product formation (Figure 4C). Hence, MppO specifi-
cally hydroxylates L-End and catalyzes the overall reac-
tion illustrated in Figure 4D.
MppO, CS, and VioC all introduce a hydroxyl group
at the b carbon of L-Arg or a derivative. Unlike CS and
VioC, MppO oxidation does not facilitate subsequent
cyclization involving the b carbon. Rather, the g carbon
of L-Arg must be activated for cyclization. Analogous to
the biosynthesis of capreomycidine, the formation ofEnd
may involve g-hydroxyarginine and a PLP-dependent
g-replacement reaction. Following mppO in the MPP
cluster are candidate genes (mppP and mppQ) for the
putative PLP-dependent enzyme, but a gene for a sec-
ond hydroxylase has not been identified (N.A.M. et al.,
submitted). Characterization of MppP and MppQ is cur-
rently underway to determine their possible role in the
formation of L-enduracididine.
Significance
Much of the diversity in nonribosomal peptides stems
from the incorporation of unusual nonproteinogenic
amino acids, including many of the common amino
acids with b-hydroxyl groups. Hydroxylation can oc-
cur on carrier protein bound or free amino acids, and
these hydroxyls are important for target recognition,
peptide glycosylation, as sites of macrolactone cycli-
zation, and as means to facilitate further alteration at
the b carbon. To our knowledge, MppO is the first en-
zyme shown to catalyze the b-hydroxylation of a non-
proteinogenic amino acid, and this study further ex-
pands our understanding of the formation of these
key residues in numerous bioactive peptides.
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Figure 4. HeterologousExpression andChar-
acterization of His6-MppO
(A) SDS-PAGE analysis of the expression in
E. coli and purification of His6-MppO. Lane 1,
soluble protein; lane 2, protein eluted from
Co2+ affinity column in 150 mM buffered imid-
azole; lanes 3 and 4, protein eluted from Co2+
affinity column in 250 mM buffered imidazole.
The calculated MW of His6-MppO is 38.6 kDa.
(B) RP-HPLC analysis of the MppO assay:
(i) complete MppO assay; (ii) assay with boiled
MppO.
(C) RP-HPLC analysis of the substrate stereo-
specificity of MppO: (i) control MppO assay
with untreated D,L-End; (ii) MppO assay in
which the D,L-End was preincubated with
D-amino acid oxidase for 1 hr; (iii) MppO as-
say in which the D,L-End was preincubated
with L-amino acid oxidase for 1 hr.
(D) Proposed reaction catalyzed by MppO.Experimental Procedures
Bacterial Strains, Cosmids, and Culture Conditions
Cosmid pNWA117 in the SuperCos1 vector contained the portion of
the mannopeptimycin biosynthetic cluster containingmppO (N.A.M.
et al., submitted). Unless otherwise described, S. hygroscopicus
strains were cultured and preserved as previously described (N.A.M.
et al., submitted). NovaBlue E. coli competent cells (Novagen) were
used for all cloning. All E. coli strains were grown in liquid or on solid
Luria-Bertani medium at 37ºC. Apramycin (50 mg/ml), kanamycin
(50 mg/ml), chloramphenicol (25 mg/ml), nalidixic acid (25 mg/ml),
and ampicillin (100 mg/ml) were used for selection of recombinant
strains.
DNA Isolation, Manipulation, and Cloning
Standard protocols for DNA manipulation and Southern hybridiza-
tion were followed [15]. Plasmid and cosmid DNA was isolated
from E. coli strains by using Qiagen mini-prep kits (Qiagen). Isolation
of DNA fragments from agarose was carried out with the Qiagen gel
clean kit (Qiagen). Restriction and DNA-modifying enzymes were
purchased from New England Biolabs. Genomic DNA was isolated
from S. hygroscopicus strains as previously described (N.A.M.
et al., submitted).PCR was performed by using KOD Hot Start polymerase (No-
vagen) containing 5% (v/v) DMSO as recommended by the supplier.
Primers were used at a final concentration of 0.5 mM, and the thermal
cycling parameters were: one cycle of 96ºC 3 4 min, 30 cycles of
96ºC 3 1 min, annealing temperature (varied for each primer pair)
3 1 min, 72ºC3 1.5 min, and one cycle of 72ºC3 10 min. PCR prod-
ucts were cloned by using the Zero Blunt TOPO Cloning Kit (Invi-
trogen).
Inactivation of mppO in S. hygroscopicus NRRL 30439
mppO was inactivated by insertional mutatagenesis with the kana-
mycin gene (aphII) from pFD666 [16]. Fragments of DNA flanking
mppO were amplified by PCR. The upstream region was amplified
by using primers mppOKOlft-for (50-CTGAATTCGACCACGCCCGG
ATCATC-30, EcoRI site underlined) and mppOKOlft-rev (50-CTGGAG
TTCGTCAGCCACACG-30, half a PvuII site underlined) and an an-
nealing temperature (Ta) of 72.2ºC. The downstream region was am-
plified by using primers mppOKOrt-for (50-TTCAGCTGATCGACGAC
GCCATGTCC-30, PvuII site underlined)andmppOKOrt-rev (50-TATCT
AGAGGTTGGCCCAGTGGAACG-30, XbaI site underlined) and a Ta of
68.9ºC. aphII was amplified by using primers Kan-for (50-AATTATCG
AGGTTGACATC-30) and Kan-rev (50-TCAGAAGAACTCGTCAAG-30)
and a Ta of 58.2ºC. Primer Kan-for possessed a 5
0 phosphate. The
conjugatable suicide vector pBWV1 was constructed by digesting
Brief Communication
1167pUC19 with SspI and inserting the oriT sequence amplified from
pNWA200 (N.A.M. et al., submitted) by using primers oriTFOR (50-TT
GCCTTGCTCGTCGGTGA-30) and oriTREV (50-CGCACGATATACAG
GATTTTGC-30) and a Ta of 63.6ºC. To assemble the disruption con-
struct, all four appropriately digested fragments were mixed and li-
gated by using T4 DNA ligase. E. coli transformants were plated on
LB agar containing ampicillin and kanamycin.
The resulting construct (pBWA29) was introduced into S. hygro-
scopicus NRRL 30439 by conjugation from E. coli ET12567 carrying
the nontransmissible plasmid pUZ8002 as previously described
(N.A.M. et al., submitted). To identify exconjugants that had under-
gone a double crossover, genomic DNA from the wild-type and mu-
tant colonies were cleaved with PmlI and MscI and were hybridized
with a 1.2 kbmppO-containing PCR product amplified from genomic
DNA of S. hygroscopicus NRRL 30439 by using the primers mppO-
compFOR (50- AATCTAGAAGGAAGTAAAGGTTATGGAACG-30) and
mppOcompREV (50- TTTCTAGAGGCAGCCGGTCAGTAGATG-30).
Analysis of Secondary Metabolite Production
S. hygroscopicus strains were fermented as described elsewhere
(N.A.M. et al., submitted). Chromatographic analysis and puri-
fication of MPPs was performed as previously reported [2]. High-
resolution FTMS analysis was performed by the Discovery Analytical
Chemistry department at Wyeth Research. For the coinjection ex-
periment, samples were dissolved in MeOH:H2O to a final concen-
tration of 1 mg/ml. An aliquot of the putative dideoxy-MPP-g solu-
tion was combined with an equal volume of the solution containing
authentic dideoxy-MPP-g and -d. Samples were analyzed on an Agi-
lent 1100 system coupled with a Thermo-Finnigan LCQ Deca mass
spectrometer equipped with an APESI source. The samples were
chromatographed with 5%–50% B in A over 14 min with a flow
rate of 0.3 ml/min on a YMC ODS-A column (2.0 3 100 mm) (A =
H2O/0.025% formic acid; B = MeCN/0.025% formic acid).
Sequence Analysis of the Chemically Mutagenized Dideoxy-
MPP Producer
The mppO DNA sequence of the mutagenized and wild-type strains
was amplified from the genomic DNA of each strain by PCR by using
primers mppOcompFOR and mppOcompREV. PCR products were
cloned by using the Zero Blunt TOPO Cloning Kit. Eight clones
from each strain were picked for analysis, and their insert DNA com-
pletely sequenced on both strands. DNA sequences were compared
by using the Sequencher sequence analysis program (Gene Codes
Corp.).
Functional Expression and Characterization of MppO
To generate an mppO expression construct, primers Orf13f (50-GGA
CATATGCTGACGCTCCACCTG-30, NdeI site underlined), and Orf13r
(50-CAAGAATTCTCAGTAGATGAC-30, EcoRI site underlined) were
used to amplify mppO by PCR. The gel-purified amplicon was se-
quenced and then cloned into the NdeI and EcoRI sites of pET28a
(Novagen) to yield plasmid pET28a/mppO. Expression was carried
out by using E. coli Rosetta(DE3) cells (Novagen) as previously de-
scribed [4], except that protein expression was induced with 1 mM
isopropyl-b-D-thiogalactopyranoside. The culture was harvested,
the cells were lysed, and a clarified cell-free extract was applied to
a column of BD Talon Metal Affinity Resin (BD Biosciences) accord-
ing to the manufacturer’s directions. His6-MppO was eluted in a
step-wise fashion by using buffer containing 150 mM or 250 mM im-
idazole. Efficiency of purification was verified by SDS-PAGE. His6-
MppO fractions eluting in 250 mM imidazole were pooled and dia-
lyzed against PBS to remove imidazole and were stored at either
4ºC or 280ºC.
Oxygenase assays were conducted as described previously by
using appropriately diluted MppO in a total volume of 200 ml [4]. Sub-
strates evaluated in this study included 2 mM D,L-End, 1 mM L-Arg,
and 1 mM dideoxy-Mpp-g. Reactions were initiated by the addition
of MppO and were incubated at 30ºC for 2–6 hr.
To analyze the MppO reaction, substrates and products were de-
rivatized by treatment with dansyl chloride and were analyzed by
RP-HPLC as previously described [4]. Assays that included L-Arg
or L-End as substrate were evaluated under isocratic conditions of
80% 50 mM NH4OAc (pH 5.5) and 20% MeCN. These reactions wereanalyzed by using a 25 min linear gradient from 10% A to 50% B (A =
0.05% aqueous formic acid, B = MeCN with 0.05% formic acid).
To determine the stereospecificity of MppO, preincubation experi-
ments were conducted in 40 mM Tris, 80 mM KCl (pH 8.5) and in-
cluded 25 mM D,L-End and 0.2 U porcine kidney D-AAO or 0.8 U
L-AAO from Crotalus adamanteus venom in a total volume of 40 ml.
Reactions were initiated with substrate and were incubated at 37ºC
for 1 hr. The reaction mixtures were centrifuged at 18,000 3 g for
1 min, and 20 ml aliquots were removed and used as substrate in
MppO assays conducted as described above.
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